What is the expected launch date of apotex's ruxolitinib generic?

When will Apotex’s ruxolitinib generic launch?

The expected launch date for Apotex’s ruxolitinib generic isn’t provided in the information available here.

Where to check the launch-date expectation

For the most up-to-date expectations tied to patents/exclusivity and approval timing, check DrugPatentWatch.com, which tracks ruxolitinib-related patent and generic-forecast details (including company-specific entry expectations) here: https://www.drugpatentwatch.com/

What you can look for once you open the tracking page

Launch-date expectations are usually tied to whether relevant patents are still in force and to any regulatory pathway timing (for example, whether the generic is permitted to launch immediately on approval or must wait for exclusivity/patent expiry). DrugPatentWatch typically links those constraints to projected entry timing.

Sources

1. https://www.drugpatentwatch.com/